Investors in Diagnósticos da América S.A. (BVMF:DASA3) had a good week, as its shares rose 9.4% to close at R$3.26 following the release of its quarterly results. It looks like a credible result overall - although revenues of R$2.4b were what the analysts expected, Diagnósticos da América surprised by delivering a (statutory) profit of R$0.13 per share, an impressive 158% above what was forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Taking into account the latest results, the consensus forecast from Diagnósticos da América's twelve analysts is for revenues of R$9.64b in 2027. This reflects a credible 5.6% improvement in revenue compared to the last 12 months. Earnings are expected to improve, with Diagnósticos da América forecast to report a statutory profit of R$0.35 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of R$9.71b and earnings per share (EPS) of R$0.34 in 2027. So the consensus seems to have become somewhat more optimistic on Diagnósticos da América's earnings potential following these results.
Check out our latest analysis for Diagnósticos da América
There's been no major changes to the consensus price target of R$4.05, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Diagnósticos da América, with the most bullish analyst valuing it at R$5.50 and the most bearish at R$2.50 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. One thing stands out from these estimates, which is that Diagnósticos da América is forecast to grow faster in the future than it has in the past, with revenues expected to display 4.5% annualised growth until the end of 2027. If achieved, this would be a much better result than the 0.7% annual decline over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 12% annually for the foreseeable future. So although Diagnósticos da América's revenue growth is expected to improve, it is still expected to grow slower than the industry.
The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Diagnósticos da América's earnings potential next year. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Diagnósticos da América's revenue is expected to perform worse than the wider industry. The consensus price target held steady at R$4.05, with the latest estimates not enough to have an impact on their price targets.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Diagnósticos da América going out to 2028, and you can see them free on our platform here..
And what about risks? Every company has them, and we've spotted 1 warning sign for Diagnósticos da América you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.